Jan-Eric Wilhelm Ahlfors

Vorstandsvorsitzender bei Total ReCord, Inc.

Health Technology

Profil

Jan-Eric Wilhelm Ahlfors is the founder of Fortuna Fix, Inc. He currently holds the position of President & Chief Executive Officer at Total ReCord, Inc.

Aktive Positionen von Jan-Eric Wilhelm Ahlfors

Unternehmen	Position	Beginn
Total ReCord, Inc. Total ReCord, Inc. Medical SpecialtiesHealth Technology Total ReCord, Inc. develops regeneration products for nervous system. Its products include regeneration matrix, mobilized adult stem cell and spherogel. Total ReCord was founded by Jan-Eric W. Ahlfors in 2005 and is headquartered in Worcester, MA.	Vorstandsvorsitzender	01.01.2005
Fortuna Fix, Inc. Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada.	Vorstandsvorsitzender	-

Alle aktiven Positionen von Jan-Eric Wilhelm Ahlfors

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jan-Eric Wilhelm Ahlfors im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Total ReCord, Inc. Total ReCord, Inc. Medical SpecialtiesHealth Technology Total ReCord, Inc. develops regeneration products for nervous system. Its products include regeneration matrix, mobilized adult stem cell and spherogel. Total ReCord was founded by Jan-Eric W. Ahlfors in 2005 and is headquartered in Worcester, MA.	Health Technology
Fortuna Fix, Inc. Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an